Telisotuzumab vedotin (Teliso-V) monotherapy in patients (pts) with previously treated c-Met-overexpressing (OE) advanced non-small cell lung cancer (NSCLC). için istatistikler
Toplam ziyaret
views | |
---|---|
Telisotuzumab vedotin (Teliso-V) monotherapy in patients (pts) with previously treated c-Met-overexpressing (OE) advanced non-small cell lung cancer (NSCLC). | 0 |
Aylık toplam ziyaret
views | |
---|---|
Ocak 2024 | 0 |
Şubat 2024 | 0 |
Mart 2024 | 0 |
Nisan 2024 | 0 |
Mayıs 2024 | 0 |
Haziran 2024 | 0 |
Temmuz 2024 | 0 |